|
Volumn 23, Issue 1, 2009, Pages 1-2
|
Early Rheumatoid Arthritis
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DISEASE MODIFYING ANTIRHEUMATIC DRUG;
CARDIOVASCULAR RISK;
CLINICAL STUDY;
COMBINATION CHEMOTHERAPY;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
EDITORIAL;
GENETIC SUSCEPTIBILITY;
GENOTYPE;
HEALTH CARE FACILITY;
HEALTH ECONOMICS;
HUMAN;
MEDICAL LITERATURE;
MONOTHERAPY;
NONHUMAN;
OBSERVATIONAL STUDY;
PATHOGENESIS;
PATIENT CARE;
PHYSIOTHERAPY;
PRIORITY JOURNAL;
PROGNOSIS;
RHEUMATOID ARTHRITIS;
RISK ASSESSMENT;
ARTHRITIS, RHEUMATOID;
EARLY DIAGNOSIS;
HUMANS;
|
EID: 60449096600
PISSN: 15216942
EISSN: None
Source Type: Journal
DOI: 10.1016/j.berh.2009.01.004 Document Type: Editorial |
Times cited : (3)
|
References (0)
|